Paul Conyngham used AI to pinpoint the mutations in his dog Rose's tumor — and used the data to have a treatment made just for her ...

In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...

An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie, using artificial intelligence tools such as ChatGPT as part of the process.

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

Talk about being a dedicated paw-rent. When his 8-year-old dog Rosie had mere months to live due to deadly mast cell cancerous tumors, Australian tech entrepreneur Paul Conyngham took matters into his ...

Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...

It will fund clinical trials of vaccines, which are therapeutic and often experimental, that activate the immune system to ...

Paul Conyngham claims he used AI tools like ChatGPT and AlphaFold to create custom mRNA vaccines that helped cure his dog’s cancer after traditional treatments failed to stop the tumour.

HealthLink discusses the research for a colon cancer vaccine with UW Medicine’s Cancer Vaccine Institute.

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...

HHS plans 200M cancer vaccine initiative to fund public-private partnerships studying vaccines for high-risk cancer patients.